Skip to content

Evaluation of the efficacy of a skin moisturizer on mild to moderate atopic dermatitis

Evaluation of the efficacy of a skin moisturizer on mild to moderate atopic dermatitis - Efficacy of a skin moisturizer on atopic dermatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030829
Enrollment
30
Registered
2018-01-18
Start date
2018-01-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

Apply about 1.25 g, 2.5 FTU, of the test moisturizer for face and neck skin twice a day for approximate four weeks. Apply about 2 g, 4 FTU, of the test or control moisturizer for right or left upper e

Sponsors

INFORWARD inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Adults who live in the suburbs of Tokyo 2)Adults who understand Japanese Language 3)Atopic dermatitis patients with mild to moderate severity on upper extremity, face, and neck.

Exclusion criteria

Exclusion criteria: 1)Atopic dermatitis patients with severe severity on upper extremity, face, and neck areas diagnosed by a dermatological doctor. 2)Patients who were diagnosed with atopic dermatitis and treated by a doctor within 3 months. 3)Patients who use medicine at test site and deemed inappropriate to stop using a drug by the principal doctor. 4)People who take part in another tests of monitors about cosmetics, quasi drugs and drug within 3 months. 5)Pregnancies and lactations and lactating women, women less than six months from childbirth. 6)People who were practiced esthetic massage or skin peeling at test area within 2 weeks. 7)People who have tattoo in face or upper extremity area. 8)Dementia patients 9)Pepole who involved in this test. 10)Employee of cosmetics, quasi drugs or drugs company. 11)Subjects deemed inappropriate to participate in this study by a dermatologist.

Design outcomes

Primary

MeasureTime frame
Clinical scores assessed by severity classification of atopic dermatitis developed by the advisory committee of atopic dermatitis severity classification of Japanese Dermatological Association at the test site.

Secondary

MeasureTime frame
1) Score of skin symptoms 2) Water content 3) Trans-epidermal water loss 4) VAS 5) Skindex-16

Countries

Japan

Contacts

Public ContactKazunori Takashima

INFORWARD inc. EBISU Skin research center

takashima@inforward.co.jp03-5793-8712

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026